Enjoy complimentary customisation on priority with our Enterprise License!
The pharmaceutical glass tubing market share is expected to increase by USD 4.35 billion from 2021 to 2026, at a CAGR of 7.2%.
This pharmaceutical glass tubing market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers pharmaceutical glass tubing market segmentations by application (vials, ampoules, cartridges, and syringes) and geography (Asia, Europe, North America, and Rest of World (ROW)). The pharmaceutical glass tubing market report also offers information on several market vendors, including AccuGlass LLC, Aimer Products Ltd., Beatson Clark Ltd., Bormioli Pharma Spa, Cangzhou Four-star Glass Co. Ltd., Corning Inc., DWK Life Sciences GmbH, Jinan Snail International Co. Ltd., Jinan Youlyy Industrial Co. Ltd., Linuo Group Holdings Co. Ltd., Nippon Electric Glass Co. Ltd., Nipro Pharma Packaging International NV, Puyang Xinhe Industrial Development Co. Ltd., Richland Glass, SCHOTT AG, SGD S.A, Shandong Medicinal Glass Co. Ltd., Stolzle-Oberglas GmbH, Turkiye Sise ve Cam Fabrikalari AS, and West Pharmaceutical Services Inc. among others.
Download the Free Report Sample to Unlock the Pharmaceutical Glass Tubing Market Size for the Forecast Period and Other Important Statistics
The increasing strategic initiatives of market players is notably driving the pharmaceutical glass tubing market growth, although factors such as product recalls may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the pharmaceutical glass tubing industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Pharmaceutical Glass Tubing Market Driver
The increasing strategic initiatives of market players is one of the key drivers supporting the pharmaceutical glass tubing market growth. For instance, in August 2021, Serum Institute of India Pvt. Ltd. acquired a 50% stake in SCHOTT Kaisha to become SCHOTT's joint venture partner and secure its pharmaceutical packaging supply. In May 2021, Stevanato Group announced a licensing agreement with Corning Inc. to offer biopharmaceutical companies the combination of Corning's Valor RTU Vials with Stevanato's EZ-fill secondary packaging solution. With the increasing demand for glass tubing from end-users, vendors are opting for M and A and strategic alliances to improve their market reach and customer base. These strategic alliances and partnerships among vendors are helping them enhance their operations and increase their geographic presence. Thus, such activities will drive the growth of the global pharmaceutical glass tubing market during the forecast period.
Key Pharmaceutical Glass Tubing Market Trend
The surge in demand due to COVID-19 is one of the key pharmaceutical glass tubing market trends that is contributing to the market growth. Since the outbreak of the COVID-19 pandemic in March 2020, many vendors in the market have focused on increasing their vial and syringe production capacity to meet the surging global demand for COVID-19 drugs and vaccines. For instance, in April 2020, the United States Food and Drug Administration (US FDA) launched the COVID-19 Treatment Acceleration Program (CTAP) to authorize new treatments and conduct trials for potential drugs to treat COVID-19. As of January 2022, more than 670 COVID-19 drug development programs were in the planning stage, while the US FDA had reviewed more than 470 trials, and 14 COVID-19 treatments had been currently authorized by the US FDA for emergency use. Such increasing drug development programs will [propel the market growth during the forecast period.
Key Pharmaceutical Glass Tubing Market Challenge
Product recalls is one of the factors hindering the pharmaceutical glass tubing market growth. For instance, in June 2021, Teva Pharmaceutical Industries Ltd. issued a voluntary recall of one lot of Topotecan Injection 4 mg/4 mL as a glass particle was observed inside one vial. After further examination, two other particulates were found, including a grey silicone particle and a translucent, colorless cotton fiber. However, product recalls negatively impact a company's revenue and its long-term prospects by hampering consumer confidence, which impacts the sales of its products and leads to a loss of faith among users. It can create pitfalls such as low-volume generation and limited product demand, leading to significant financial losses for vendors. Thus, such market challenges can negatively impact the growth of the global pharmaceutical glass tubing market during the forecast period.
This pharmaceutical glass tubing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global pharmaceutical glass tubing market as a part of the global healthcare supplies market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the pharmaceutical glass tubing market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the pharmaceutical glass tubing market encompasses successful business strategies deployed by the key vendors. The pharmaceutical glass tubing market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The pharmaceutical glass tubing market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the pharmaceutical glass tubing market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
46% of the market's growth will originate from Asia during the forecast period. China and Japan are the key markets for the pharmaceutical glass tubing market in Asia. Market growth in this region will be faster than the growth of the market in other regions.
The increasing expenditure on prescription drugs and over-the-counter (OTC) drugs will facilitate the pharmaceutical glass tubing market growth in Asia over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
Since the outbreak of the COVID-19 pandemic in March 2020, various COVID-19 drugs and vaccines have been approved by health authorities in the region. Furthermore, governments in China and India took measures to increase production capacity and shortages of crucial drugs required for treating COVID-19 patients. These factors supported the growth of the regional market. The region will continue to contribute to the growth of the global pharmaceutical glass tubing market during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The pharmaceutical glass tubing market share growth by the vials segment will be significant during the forecast period. The process of choosing the right packaging to meet specific drug requirements is complex. Various pharmaceutical companies choose glass vials due to their inherent characteristics and suitability to store drugs safely. Sensitive pharmaceutical drugs, generic drugs, and modern biotech drugs can be stored safely due to the barrier properties of glass. Vendors in the market offer high-quality glass tubes used by primary packaging converters to produce premium quality vials for the pharmaceutical industry. Such characteristics will drive the segment growth during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the pharmaceutical glass tubing market size and actionable market insights on post COVID-19 impact on each segment.
Pharmaceutical Glass Tubing Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Decelerate at a CAGR of 7.2% |
Market growth 2022-2026 |
$ 4.35 billion |
Market structure |
Fragmented |
YoY growth (%) |
8.97 |
Regional analysis |
Asia, Europe, North America, and Rest of World (ROW) |
Performing market contribution |
Asia at 46% |
Key consumer countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
AccuGlass LLC, Aimer Products Ltd., Beatson Clark Ltd., Bormioli Pharma Spa, Cangzhou Four-star Glass Co. Ltd., Corning Inc., DWK Life Sciences GmbH, Jinan Snail International Co. Ltd., Jinan Youlyy Industrial Co. Ltd., Linuo Group Holdings Co. Ltd., Nippon Electric Glass Co. Ltd., Nipro Pharma Packaging International NV, Puyang Xinhe Industrial Development Co. Ltd., Richland Glass, SCHOTT AG, SGD S.A, Shandong Medicinal Glass Co. Ltd., Stolzle-Oberglas GmbH, Turkiye Sise ve Cam Fabrikalari AS, and West Pharmaceutical Services Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Application
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.